Novo Nordisk Aktie
| 53,64EUR | 0,90EUR | 1,71% |
WKN DE: A3EU6F / ISIN: DK0062498333
Diese Analysten bewerten die Novo Nordisk-Aktie
| Analyst | Buy | Hold | Sell | Kursziel | Abstand | Datum |
|---|---|---|---|---|---|---|
| Jefferies & Company Inc. | 270,00DKK | -32,00% | 23.01.26 | |||
| Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | 415,00DKK | 4,52% | 23.01.26 | |||
| Goldman Sachs Group Inc. | 436,00DKK | 9,81% | 22.01.26 | |||
| Barclays Capital | 360,00DKK | -9,33% | 22.01.26 | |||
| UBS AG | 390,00DKK | -1,78% | 21.01.26 | |||
| Deutsche Bank AG | 475,00DKK | 19,63% | 16.01.26 | |||
| JP Morgan Chase & Co. | 350,00DKK | -11,85% | 15.01.26 | |||
| Bernstein Research | 540,00DKK | 36,00% | 07.11.25 |
Historische Rating-Entwicklung
|
0
Buy
0
Hold
0
Sell
Aktuell
|
0
Buy
0
Hold
0
Sell
vor 1/2 Jahr
|
0
Buy
0
Hold
0
Sell
vor 1 Jahr
|